218 related articles for article (PubMed ID: 29974097)
1. Synthesis, in vitro cytotoxicity, and structure-activity relationships (SAR) of multidentate oxidovanadium(iv) complexes as anticancer agents.
Ni L; Zhao H; Tao L; Li X; Zhou Z; Sun Y; Chen C; Wei D; Liu Y; Diao G
Dalton Trans; 2018 Jul; 47(30):10035-10045. PubMed ID: 29974097
[TBL] [Abstract][Full Text] [Related]
2. Exploring Anticancer Activities and Structure-Activity Relationships of Binuclear Oxidovanadium(IV) Complexes.
Ni L; Chang W; Zhu S; Zhang Y; Chen P; Zhang H; Zhao H; Zha J; Jiang S; Tao L; Zhou Z; Wang X; Liu Y; Diao G
ACS Appl Bio Mater; 2021 Dec; 4(12):8571-8583. PubMed ID: 35005923
[TBL] [Abstract][Full Text] [Related]
3. Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel apoptosis-inducing anticancer agent.
Narla RK; Dong Y; D'Cruz OJ; Navara C; Uckun FM
Clin Cancer Res; 2000 Apr; 6(4):1546-56. PubMed ID: 10778988
[TBL] [Abstract][Full Text] [Related]
4. New oxidovanadium(IV) N-acylhydrazone complexes: promising antileishmanial and antitrypanosomal agents.
Benítez J; Cavalcanti de Queiroz A; Correia I; Alves MA; Alexandre-Moreira MS; Barreiro EJ; Lima LM; Varela J; González M; Cerecetto H; Moreno V; Pessoa JC; Gambino D
Eur J Med Chem; 2013 Apr; 62():20-7. PubMed ID: 23353731
[TBL] [Abstract][Full Text] [Related]
5. Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.
Holder AA; Taylor P; Magnusen AR; Moffett ET; Meyer K; Hong Y; Ramsdale SE; Gordon M; Stubbs J; Seymour LA; Acharya D; Weber RT; Smith PF; Dismukes GC; Ji P; Menocal L; Bai F; Williams JL; Cropek DM; Jarrett WL
Dalton Trans; 2013 Sep; 42(33):11881-99. PubMed ID: 23783642
[TBL] [Abstract][Full Text] [Related]
6. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
7. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
[TBL] [Abstract][Full Text] [Related]
8. Influence of Primary Ligands (ODA, TDA) on Physicochemical and Biological Properties of Oxidovanadium (IV) Complexes with Bipy and Phen as Auxiliary Ligands.
Pranczk J; Tesmar A; Wyrzykowski D; Inkielewicz-Stępniak I; Jacewicz D; Chmurzyński L
Biol Trace Elem Res; 2016 Nov; 174(1):251-258. PubMed ID: 27048276
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic oxidovanadium(IV) complexes of tridentate halogen-substituted Schiff bases: First dinuclear V(IV) complexes with O → V
Rudbari HA; Saadati A; Aryaeifar M; Correia I; Marques F; Blacque O; Micale N
Bioorg Med Chem Lett; 2021 Oct; 49():128285. PubMed ID: 34303813
[TBL] [Abstract][Full Text] [Related]
10. Possible Selective Cytotoxicity of Vanadium Complex on Breast Cancer Cells Involving Pathophysiological Pathways.
El-Shafey ES; Elsherbiny ES
Anticancer Agents Med Chem; 2019; 19(17):2130-2139. PubMed ID: 31696812
[TBL] [Abstract][Full Text] [Related]
11. Self-recognition of the racemic ligand in the formation of homochiral dinuclear V(V) complex: In vitro anticancer activity, DNA and HSA interaction.
Kazemi Z; Amiri Rudbari H; Mirkhani V; Sahihi M; Moghadam M; Tangestaninejad S; Mohammadpoor-Baltork I; Kajani AA; Azimi G
Eur J Med Chem; 2017 Jul; 135():230-240. PubMed ID: 28456032
[TBL] [Abstract][Full Text] [Related]
12. DNA damage induction and antiproliferative activity of vanadium(V) oxido monoperoxido complex containing two bidentate heteroligands.
Andrezálová L; Gbelcová H; Duračková Z
J Trace Elem Med Biol; 2013 Jan; 27(1):21-6. PubMed ID: 22575540
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
14. Characterization and cytotoxic effect of aqua-(2,2',2''-nitrilotriacetato)-oxo-vanadium salts on human osteosarcoma cells.
Tesmar A; Wyrzykowski D; Kruszyński R; Niska K; Inkielewicz-Stępniak I; Drzeżdżon J; Jacewicz D; Chmurzyński L
Biometals; 2017 Apr; 30(2):261-275. PubMed ID: 28204978
[TBL] [Abstract][Full Text] [Related]
15. Spermicidal activity of oxovanadium(IV) complexes of 1, 10-phenanthroline, 2,2'-bipyridyl, 5'-bromo-2'-hydroxyacetophenone and derivatives in humans.
D'Cruz OJ; Dong Y; Uckun FM
Biol Reprod; 1999 Feb; 60(2):435-44. PubMed ID: 9916012
[TBL] [Abstract][Full Text] [Related]
16. Insights into the mechanisms underlying the antitumor activity of an oxidovanadium(IV) compound with the antioxidant naringenin. Albumin binding studies.
Islas MS; Naso LG; Lezama L; Valcarcel M; Salado C; Roura-Ferrer M; Ferrer EG; Williams PA
J Inorg Biochem; 2015 Aug; 149():12-24. PubMed ID: 25957189
[TBL] [Abstract][Full Text] [Related]
17. Ternary oxovanadium(IV) complexes with amino acid-Schiff base and polypyridyl derivatives: synthesis, characterization, and protein tyrosine phosphatase 1B inhibition.
Lu L; Yue J; Yuan C; Zhu M; Han H; Liu Z; Guo M
J Inorg Biochem; 2011 Oct; 105(10):1323-8. PubMed ID: 21864810
[TBL] [Abstract][Full Text] [Related]
18. Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.
Roy S; Böhme M; Dash SP; Mohanty M; Buchholz A; Plass W; Majumder S; Kulanthaivel S; Banerjee I; Reuter H; Kaminsky W; Dinda R
Inorg Chem; 2018 May; 57(10):5767-5781. PubMed ID: 29741373
[TBL] [Abstract][Full Text] [Related]
19. Vanadium complex: an appropriate candidate for killing hepatocellular carcinoma cancerous cells.
Bakhshi Aliabad H; Khanamani Falahati-Pour S; Ahmadirad H; Mohamadi M; Hajizadeh MR; Mahmoodi M
Biometals; 2018 Dec; 31(6):981-990. PubMed ID: 30255365
[TBL] [Abstract][Full Text] [Related]
20. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
